Side by Side
Compare
Read two to four stocks on the same scale — return, valuation and volatility in one table.
Selected1Y Return
Period Return
Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.
| Metric | AKRO | PFE |
|---|---|---|
| Return | ||
| Last Price | — | 28.45 |
| Daily Change | — | − 1.25% |
| Period ReturnPast Year | + 20.27% | + 13.89% |
| Valuation | ||
| Market Cap | $4.50 B | $162 B |
| P/E Ratio | — | — |
| Dividend Yield | — | — |
| Net MarginTrailing 12M | — | — |
| Risk | ||
| Beta | — | — |
| 52-Week Range | — | — |
| Company | ||
| Sector | — | Health Care |
| Industry | Biotechnology | Pharmaceuticals |
Company
- AKROBiotechnology
- PFEHealth Care · Pharmaceuticals
Metrics could not be loaded for AKRO, PFE: P/E, dividend, beta and the 52-week range stay empty in that column.
FinnhubUpdated 23:00
To Understand This